| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |